Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.

scientific article published on 15 January 2018

Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S15010-017-1113-1
P698PubMed publication ID29335905

P50authorRosa ZampinoQ59158585
Aldo MarroneQ64342034
Valerio RosatoQ87153856
Luigi E. AdinolfiQ89603631
Luca RinaldiQ89939497
P2093author name stringAntonio Chirianni
Luca Fontanella
Vincenzo Messina
Guido Piai
Antonio Ascione
Giovanna Valente
Vincenzo Sangiovanni
Pasquale Orabona
Carmela Buonomo
Nicolina de Rosa
P2860cites workNon-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis BQ57782726
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogsQ58815702
Determination of reliability criteria for liver stiffness evaluation by transient elastographyQ59352739
Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patientsQ61764174
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis BQ82822290
Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis BQ84328358
Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectivesQ26822664
Prediction models of hepatocellular carcinoma development in chronic hepatitis B patientsQ28066959
Hepatitis B virus infection--natural history and clinical consequencesQ29617961
Non-invasive assessment of liver fibrosis in chronic hepatitis B.Q30427489
Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agentsQ30439873
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracyQ33767530
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyQ34317204
Natural history and prognostic factors for chronic hepatitis type BQ34393564
Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis.Q34437952
Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective studyQ34450720
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.Q34544284
The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapyQ35135141
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver diseaseQ36014015
Serial Liver Stiffness Measurements and Monitoring of Liver-Transplanted Patients in a Real-Life Clinical PracticeQ37587196
Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort studyQ37730962
Long-term therapy for chronic hepatitis B: hepatitis B virus DNA suppression leading to cirrhosis reversalQ38097858
Hepatitis B: are non-invasive markers of liver fibrosis reliable?Q38174256
Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.Q38224416
Reversibility of hepatitis B virus cirrhosis after therapy: who and why?Q38295837
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infectionQ38692559
A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B.Q40238088
Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B.Q41835262
Hepatitis B cure: From discovery to regulatory approval.Q41952398
Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.Q42210609
Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.Q42253735
Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogueQ42255620
Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examinationQ42285772
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.Q42947269
Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B.Q43255316
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.Q44707599
Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriersQ45149873
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosisQ46415674
On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.Q51584406
Liver biopsy: The best, not the gold standardQ56833893
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patientsQ57735452
P433issue2
P304page(s)231-238
P577publication date2018-01-15
P1433published inInfectionQ15710156
P1476titleInfluence of antiviral therapy on the liver stiffness in chronic HBV hepatitis
P478volume46

Reverse relations

Q92933109Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBVcites workP2860

Search more.